Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
alkotinib (ZG0418) / Suzhou Zelgen
NCT04211922: Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib	Terminated	2	4	RoW	Alkotinib Capsules, ZG0418	Suzhou Zelgen Biopharmaceuticals Co.,Ltd	ALK-positive Non-small Cell Lung Cancer	10/22	10/22
NCT03607188: Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer	Completed	1	17	RoW	Alkotinib, ZG0418	Suzhou Zelgen Biopharmaceuticals Co.,Ltd	Non-small Cell Lung Cancer	10/22	10/22